Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013


Pharmaceutical Sales & Brand Management Conference

08 Jul 2013 - 09 Jul 2013 - Las Vegas, NV , USA



Bookmark and Share


How does the pharmaceutical salesperson of the future delivery value?

The answer is no longer simple. What was once a standard operating procedure has been thrown into flux. The market is in the midst of a sea change and pharmaceutical companies are now re-evaluating brand & life cycle management, sales team design & incentives, physician & payer relationships and social media campaigns. Decisions made on these strategic issues will have a direct impact on the organization’s ability to grow as a brand.

However significant change brings new opportunity. The best strategic plans will chart new courses and create new market leaders. Sales teams of the future will solidify new bonds with customers driving brand value. New marketing campaigns will harness the voice of the customer to enhance public awareness. Access will be created by satisfying needs. But only those who understand this dynamic market and develop the best strategic tools will enjoy the successes this new future holds.

GTC’s Pharmaceutical Sales & Brand Management Conference assembles key strategic leaders to discuss and bring clarity to a transitioning market. They will discuss issues, including:
  
  · Incentivizing sales teams
  · Selling to managed care systems
  · Healthcare reform
  · Market access
  · Social media campaigns
  · Managing specialty drugs
  · Biologic strategies
  · ACOs and their relationships with pharma

This is a unique opportunity to hear from and network with your peers in an exclusive setting devoted entirely to pharmaceutical sales, marketing and brand management.


2013 Pharmaceutical Sales & Brand Management Conference Committee

Conference Advisory Board Members:
Dan Brennan, Vice President, Neurology,
 Lundbeck
Dan Camardo, Senior Director, Marketing Operations,
 Astellas Pharma US
Frank Dolan, Director, Synergy Sales Force,
 Amylin Pharmaceuticals
Christine Fiore, Compliance Business Partner, Commercial Compliance,
 Boehring Ingelheim
John Grano, Vice President, Global Sales & Marketing Effectiveness,
 Sanofi Pasteur
Kari K. Loeser, Compliance Counsel,
 Jazz Pharmaceuticals
Tom McCann, Vice President, Oncology Sales and Marketing,
 Accredo, a Division of Express Scripts

We look forward to seeing you at the conference!
 



Further information
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!